Analysts Bullish On Sun Pharma
  • Elizabeth George
  • Oct 10 2013

October 10: Sun Pharma's stock is up 50% in the last six months and almost 75% in the last year. With the second-quarter earnings season around the corner, analysts have pegged very high ranges for the company’s revenue and profit growth. Watch this segment to know why Sun Pharma has seen the growth it has and why analysts think it is a promising pick.